HomeCompareCITEW vs JNJ

CITEW vs JNJ: Dividend Comparison 2026

CITEW yields 767.46% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CITEW wins by $1955374.88M in total portfolio value
10 years
CITEW
CITEW
● Live price
767.46%
Share price
$0.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1955374.90M
Annual income
$1,556,430,831,418.50
Full CITEW calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CITEW vs JNJ

📍 CITEW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCITEWJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CITEW + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CITEW pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CITEW
Annual income on $10K today (after 15% tax)
$65,234.08/yr
After 10yr DRIP, annual income (after tax)
$1,322,966,206,705.72/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CITEW beats the other by $1,322,966,206,002.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CITEW + JNJ for your $10,000?

CITEW: 50%JNJ: 50%
100% JNJ50/50100% CITEW
Portfolio after 10yr
$977687.46M
Annual income
$778,215,416,123.14/yr
Blended yield
79.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CITEW
No analyst data
Altman Z
-1.2
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CITEW buys
0
JNJ buys
0
No recent congressional trades found for CITEW or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCITEWJNJ
Forward yield767.46%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$1955374.90M$20.0K
Annual income after 10y$1,556,430,831,418.50$827.78
Total dividends collected$1923602.45M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CITEW vs JNJ ($10,000, DRIP)

YearCITEW PortfolioCITEW Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$87,446$76,745.97$10,676$355.77+$76.8KCITEW
2$720,775$627,208.03$11,407$389.39+$709.4KCITEW
3$5,602,795$4,831,565.55$12,198$426.53+$5.59MCITEW
4$41,095,142$35,100,151.12$13,056$467.62+$41.08MCITEW
5$284,580,297$240,608,495.17$13,987$513.12+$284.57MCITEW
6$1,861,690,623$1,557,189,705.60$14,998$563.56+$1861.68MCITEW
7$11,512,523,702$9,520,514,735.03$16,098$619.52+$11512.51MCITEW
8$67,340,819,116$55,022,418,755.37$17,295$681.69+$67340.80MCITEW
9$372,844,928,447$300,790,251,992.65$18,599$750.82+$372844.91MCITEW
10$1,955,374,904,857$1,556,430,831,418.50$20,022$827.78+$1955374.88MCITEW

CITEW vs JNJ: Complete Analysis 2026

CITEWStock

It intends to identify and complete a business combination with a business combination partner focused on the technology firm in India. The company was incorporated in 2021 and is based in Washington, the District of Columbia.

Full CITEW Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CITEW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CITEW vs SCHDCITEW vs JEPICITEW vs OCITEW vs KOCITEW vs MAINCITEW vs ABBVCITEW vs MRKCITEW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.